Healthcare Services

Optical Genome Mapping Market Growth Outlook Indicating Expansion To $0.73 Billion By 2030

June 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Optical Genome Mapping Market Progress Through 2030?

The optical genome mapping market size has experienced exponential growth in recent years. It is projected to expand from $0.23 billion in 2025 to $0.29 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 29.4%. The expansion observed in the historic period can be ascribed to several factors, including the limitations of next-generation sequencing in detecting large structural variants, increased funding for genomic research, a rising prevalence of genetic disorders, the growing demand for advanced cytogenetic techniques, and technological advancements in imaging and DNA labeling.

The optical genome mapping market size is projected to experience significant expansion in the coming years, reaching $0.74 billion by 2030, driven by a compound annual growth rate (CAGR) of 25.9%. This growth throughout the forecast period is attributable to elements such as the increasing integration of ogm within clinical laboratories, rising investment in precision medicine initiatives, the growing adoption of automated genomic analysis platforms, expanding applications in oncology and hematological malignancies, and the declining costs of genomic analysis technologies. Prominent trends anticipated in the forecast period include the growing uptake of optical genome mapping in structural variant detection, increased utilization of ogm in rare disease and cancer research, a rising demand for high-resolution long-read genomic analysis, the expansion of ogm applications into clinical diagnostics, and a growing preference for the complementary use of ogm alongside sequencing technologies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

What Important Drivers Are Powering The Optical Genome Mapping Market Growth?

The burgeoning demand for precision medicine is projected to stimulate the expansion of the optical genome mapping market moving forward. Precision medicine represents a healthcare strategy that tailors medical treatments and preventive measures to an individual’s specific characteristics, such as their genetic makeup, lifestyle, and environment. The impetus for precision medicine’s demand arises from the escalating occurrence of chronic illnesses, breakthroughs in genomic technologies, augmented investment and funding, and patient calls for personalized care. optical genome mapping bolsters the effectiveness of precision medicine by delivering a thorough and precise comprehension of the genomic modifications linked to various diseases. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA sanctioned 16 novel personalized therapies for individuals with rare diseases in 2023, an increase from six in 2022. Thus, the growing need for precision medicine is propelling the growth of the optical genome mapping market.

Which Segment Groups Define The Optical Genome Mapping Market Landscape?

The optical genome mapping market covered in this report is segmented –

1) By Product: Instruments, Consumables And Reagents, Software, Services

2) By Application: Structural Variant Detection, Genome Assembly, Microbial Strain Typing, Other Applications

3) By End-User: Biotechnology And Pharmaceutical Companies, Clinical Laboratories, Academic Research Institutes, Other End-Users

Subsegments:

1) By Instruments: Optical Genome Mapping Systems, Imaging Systems, Detection And Analysis Devices

2) By Consumables And Reagents: DNA Preparation Kits, Labeling Reagents, Flow Cells

3) By Software: Data Analysis Software, Image Processing Software, Mapping Software

4) By Services: Data Analysis Services, Technical Support Services, Training And Consultation Services

What Trends Are Influencing The Optical Genome Mapping Market?

Major companies in the optic neuropathy management market are focused on developing advanced therapies, including monoclonal antibody treatment, to gain a competitive edge. Monoclonal antibodies are lab-created proteins engineered to replicate the immune system’s capacity to combat harmful pathogens such as viruses and bacteria. For example, in March 2023, Horizon Therapeutics, an Ireland-based firm, unveiled a new analysis of MRI findings concerning their drug, UPLIZNA (inebilizumab). This analysis indicated that UPLIZNA decreases the occurrence of asymptomatic optic nerve lesions in patients with neuromyelitis optica spectrum disorder (NMOSD). This demonstrates Horizon’s commitment to delivering novel treatments for rare conditions such as NMOSD, gout, and thyroid eye disease. UPLIZNA functions as a monoclonal antibody to treat NMOSD by specifically targeting and eliminating harmful B cells, thereby reducing inflammation and preventing further harm to the central nervous system and optic nerves, which ultimately leads to fewer relapses and aids in vision preservation.

Which Firms Are Competing In The Optical Genome Mapping Market?

Major companies operating in the optical genome mapping market are Bionano Genomics Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., BioSkryb Genomics, Phase Genomics Inc., Nabsys, Daicel Arbor Biosciences, OpGen, Thermo Fisher Scientific Inc., Roche Sequencing Solutions, Genomic Vision SA, INRAE French Plant Genomic Resources Center, Source BioScience, Resolve Biosciences, Arima Genomics Inc., GnuBIO Inc., Longas Technologies, GE Healthcare Life Sciences, Danaher Corporation, Strand Life Sciences, Berry Genomics, Dante Genomics

Access The Complete Optical Genome Mapping Market Report:

https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Which Region Contributes The Most To The Optical Genome Mapping Market?

North America was the largest region in the optical genome mapping market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the optical genome mapping market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Optical Genome Mapping Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=15882&type=smp

Browse Through More Reports Similar to the Global Optical Genome Mapping Market 2026, By The Business Research Company

Optic Atrophy Management Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/optic-atrophy-management-global-market-report

Peripheral Neuropathy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Diabetic Neuropathy Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-neuropathy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795